Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 6-7, 2006, Pages 456-459

  Colakoglu, Sule ^a   Alacam, Ruhi ^a   Hascelik, Gulsen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL PROTEIN; CLINDAMYCIN; ERYTHROMYCIN; ERYTHROMYCIN RESISTANCE METHYLASE B; ERYTHROMYCIN RESISTANCE METHYLASE TR; LINCOSAMIDE DERIVATIVE; MACROLIDE; MIKAMYCIN B; PENICILLIN G; PROTEIN MEFA; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; CONTROLLED STUDY; DRUG MECHANISM; LATEX AGGLUTINATION TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PUS; SPUTUM CULTURE; STREPTOCOCCUS PYOGENES; THROAT CULTURE; TURKEY (REPUBLIC);

AZITHROMYCIN; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PENICILLINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TURKEY;

EID: 33746613610     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540500546290     Document Type: Article

References (39)

1. Bisno, AL and Rijn, IV. (2000) Classification of streptococci. In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases5th edn. (pp. 2100-7). Churchill Livingstone.
2. York, MK and Gibbs, L and Perdreau-Remington, F and Brooks, GF. (1999) Characterization of antimicrobial resistance in Streptococcus pyogenes from the San Francisco Bay area of Northern California J Clin Microbiol, 37, pp. 1727-31.
3. Seppälä, H and Nissinen, A and Jarvinen, H and Huovinen, S and Henriksson, T and Herva, E and (1992) Resistance to erythromycin in group A streptococci N Engl J Med, 30, pp. 292-7.
4. Dicuonzo, G and Fiscarelli, E and Gherardi, G and Lorino, G and Battistoni, F and Landii, S and (2002) Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy Antimicrob Agents Chemother, 46, pp. 3987-90.
5. Trallero-Perez, E and Fernandez-Mazarrasa, C and Garcia-Rey, C and Bouza, E and Aguilar, L and Garcia-De-Lomas, X and (2001) Antimicrobial susceptibilities of 1684 Streptococcus pneumoniae and 2039 Streptococcus pyogenes isolates and their ecological relationships: Results of a 1-year (1998-1999) multicentre surveillance study in Spain Antimicrob Agents Chemother, 45, pp. 3334-40.
6. Martin, JM and Gren, M and Barbadora, KA and Wald, ER. (2002) Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh N Engl J Med, 346, pp. 1200-6.
7. Yan, J and Wu, HM and Huang, A and Fu, HM and Lee, CT and Wu, JJ. (2000) Prevalence of polyclonal mefA-containing erythromycin resistant group A streptococci in southern Taiwan J Clin Microbiol, 38, pp. 2475-9.
8. Seppälä H and Klaukka, T and Vuopio-Varkila, J and Muotiala, A and Helenius, H and Lager, K and (1997) The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland N Engl J Med, 337, pp. 441-6.
9. Granizo, JJ and Aguilar, L and Casal, J and Dal-Re, R and Baquero, F. (2000) Streptococcus pyogenes resistance to macrolide consumption in Spain (1986-1997) J Antimicrob Chemothe, 46, pp. 959-64.
10. Čižman M and Pokorn, M and Seme, K and Orazem, A and Paragi, M. (2001) The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens J Antimicrob Chemother, 47, pp. 475-7.
11. Fischetti, VA and Novick, RP and Ferretti, JJ. (2000) Resistance to the macrolide-lincosamide-streptogramin antibiotics. In Gram Positive Pathogens. (pp. 694-710). Washington DC: American Society for Microbiology.
12. Vester, B and Douthwaite, S. (2001) Macrolide resistance conferred by base substitutions in 23S rRNA Antimicrob Agents Chemother, 45, pp. 1-12.
13. Leclerq, R and Courvalin, P. (1991) Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria Antimicrob Agents Chemother, 35, pp. 1273-6.
14. Seppälä H and Nissinen, A and Yu, Q and Huovinen, P. (1993) Three different phenotypes of erythromycin-resistance Streptococcus pyogenes in Finland J Antimicrob Chemother, 32, pp. 885-91.
15. Leclercq, R. (2002) Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implication Clin Infect Dis, 34, pp. 482-92.
16. Leclercq, R and Courvalin, P. (1991) Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification Antimicrob Agents Chemother, 35, pp. 1267-72.
17. Weisblum, B. (1995) Insights into erythromycin action from studies of its activity as inducer of resistance Antimicrob Agents Chemother, 39, pp. 797-805.
18. Sutcliffe, J and Tait-Kamradt, A and Wondrack, L. (1996) Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: A common resistance pattern mediated by an efflux system Antimicrob Agents Chemother, 40, pp. 1817-24.
19. Weisblum, B. (1995) Erythromycin resistance by ribosomal modification Antimicrob Agents Chemother, 39, pp. 577-85.
20. Seppälä H and Skurnik, M and Soini, H and Roberts, MC and Huovinen, P. (1998) A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes Antimicrob Agents Chemother, 42, pp. 257-62.
21. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Approved Standard M100-S11. NCCLS, PennsylvaniaUSA, 2001.
22. Bingen, E and Fitoussi, F and Doit, C and Cohen, R and Tana, A and George, R and (2000) Resistance to macrolides in Streptococcus pyogenes in France in paediatric patients Antimicrob Agents Chemother, 44, pp. 1453-7.
23. Klugman, KP and Capper, T and Widdowson, CA and Koornhof, HJ and Moser, W. (1998) Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae characterization of South African isolates J Antimicrob Chemother, 42, pp. 729-34.
24. Petinaki, E and Kontos, F and Pratti, A and Skulakis, C and Maniatis, AN. (2003) Clinical isolates of macrolide-resistance Streptococcus pyogenes in central Greece Int J Antimicrob Agents, 47, pp. 67-70.
25. Giovanetti, E and Montanari, MP and Mingoia, M and Varaldo, PE. (1999) Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains Antimicrob Agents Chemother, 43, pp. 1935-40.
26. Reinert, RR and Lütticken R and Bryskier, A and Al-Lahham, A. (2003) Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the paediatric population in Germany during 2000-2001 Antimicrob Agents Chemother, 47, pp. 489-93.
27. Marjdan, M and Hoeck, M and Hahn, H and Wagner, J. (2000) Antimicrobial resistance in Streptococcus pyogenes in Berlin J Antimicrob Chemother, 46, pp. 621-3.
28. Hasenbein, ME and Warner, J and Lambert, KG and Cole, SE and Onderdonk, AB and McAdam, AJ. (2004) Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area J Clin Microbiol, 42, pp. 1559-63.
29. Cornaglia, G and Ligozzi, M and Valentini, M and Orefici, G and Fontana, R. (1996) Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995 Emerg Infect Dis, 2, pp. 339-42.
30. Cornaglia, G and Ligozzi, M and Mazzariol, A and Masala, L and Cascio, GL and Orefici, G and (1998) Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy Clin Infect Dis, 27(Suppl. 1), pp. 87-92.
31. Portillo, A and Lantero, M and Gastanares, MJ and Ruiz-Larrea, F and Torres, C. (1999) Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain Int J Antimicrob Agents, 13, pp. 137-40.
32. Acikgoz, ZC and Gocer, S and Tuncer, S. (2003) Macrolide resistance determinants of group A streptococci in Ankara, Turkey J Antimicrob Chemother, 52, pp. 110-2.
33. Detcheva, A and Facklam, RR and Beall, B. (2002) Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2001 J Clin Microbiol, 45, pp. 3831-4.
34. Jasir, A and Tana, A and Mirsalehian, A and Mirsglehian, A and Efstratiou, A and Schalen, C. (2000) High rate of tetracycline resistance in Streptococcus pyogenes in Iran: An epidemiological study J Clin Microbiol, 38, pp. 2103-7.
35. Bingen, E and Leclercq, R and Fitoussi, F and Brahimi, N and Malbruny, B and Deforche, D and (2002) Emergence of group A streptococcus strains with different mechanism of macrolide resistance Antimicrob Agents Chemother, 46, pp. 1199-1203.
36. Kataja, J and Huovinen, P and Muotiala, A and Vuopio-Varkila, J and Efstration, A and Halas, G and (1998) Clonal spread of group A streptococcus with the new type of erythromycin resistance J Infect Dis, 177, pp. 786-9.
37. KatajaJ, HuovinenP, The Macrolide Resistance Study Group, Seppälä H. Erythromycin resistance genes in group A streptococci of different georaphical origins. J Antimicrob Chemother 2000;46:789-92.
38. BaqueroF, Garcia-RodriguezA, Garcia De LomasJ, AguilarL, the Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial resistance of 914 beta-haemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-y (1996-1997) multicentre surveillence study. Antimicrob Agents Chemother 1999;43:178-80.
39. Morosini, MI and Canton, R and Loza, E and Campo, R and Almaraz, F and Baquero, F. (2003) Streptococcus pyogenes isolates with characterized macrolide resistance mechanism in Spain: In vitro activities of telithromycin and cethromycin J Antimicrob Chemother, 52, pp. 50-5.